SEAMO is very happy to announce the recipients of this year's Innovation Fund.
Aws Almufleh – Cardiology (Medicine): Building a point-of-care risk communication tool to improve perioperative risk estimation and mitigation for heart failure patients undergoing non-cardiac surgery
David Barber – Family Medicine: Assessment of screening patterns for metabolic dysfunction-associated steatotic liver disease (MASLD) in patients with diabetes mellitus within the Canadian primary care setting
Elisa Brietzke – Psychiatry: Psilocybin-assisted psychotherapy for major depressive disorder in women with a history of childhood maltreatment: A pilot trial
Tracy Cupido – Anesthesiology: Bone-enhanced ultrasound (BEUS) for facet joint injections in patients with chronic back pain: A future for ultrasound-based spinal procedures
David Hurlbut – Pathology: Integrative metabolomic and pathological characterization for precision-based rectal cancer management
Christine Law – Ophthalmology: Improving strabismus surgical outcomes: The role of high-resolution eye-tracking in predicting future surgical needs
Jordan Leitch – Anesthesiology: Continuous vital signs monitoring using a novel, non-invasive ambulatory monitor to detect and prevent perioperative cardiovascular complications during early recovery from non-cardiac surgery
Daniel Mulder – Pediatrics: Uncovering innovative inflammatory bowel disease biomarkers with neutrophil-macrophage interactions
Claudio Soares – Psychiatry: Microdosing psilocybin (non-hallucinogenic) for the management of moderate-to-severe generalized anxiety disorder (GAD): Safety, efficacy, and potential biomarker for treatment response
Stephen Vanner – Gastroenterology (Medicine): A novel pH-sensitive analgesic lacking the toxicity of conventional opioids and NSAIDs